Logo image of INGN

INOGEN INC (INGN) Stock Price, Quote, News and Overview

NASDAQ:INGN - Nasdaq - US45780L1044 - Common Stock - Currency: USD

7.07  +0.1 (+1.43%)

After market: 7.07 0 (0%)

INGN Quote, Performance and Key Statistics

INOGEN INC

NASDAQ:INGN (5/6/2025, 8:17:02 PM)

After market: 7.07 0 (0%)

7.07

+0.1 (+1.43%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High13.33
52 Week Low6.4
Market Cap190.11M
Shares26.89M
Float23.81M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-07 2025-05-07/amc
IPO02-14 2014-02-14


INGN short term performance overview.The bars show the price performance of INGN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30

INGN long term performance overview.The bars show the price performance of INGN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of INGN is 7.07 USD. In the past month the price decreased by -0.28%. In the past year, price decreased by -16.43%.

INOGEN INC / INGN Daily stock chart

INGN Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.84 230.77B
ISRG INTUITIVE SURGICAL INC 69.43 190.13B
BSX BOSTON SCIENTIFIC CORP 38.56 154.00B
SYK STRYKER CORP 30.13 144.10B
MDT MEDTRONIC PLC 15.42 105.58B
BDX BECTON DICKINSON AND CO 11.72 47.42B
EW EDWARDS LIFESCIENCES CORP 28.82 44.05B
IDXX IDEXX LABORATORIES INC 41.55 38.39B
RMD RESMED INC 26.65 35.48B
DXCM DEXCOM INC 49.41 31.97B
GEHC GE HEALTHCARE TECHNOLOGY 14.58 30.72B
PHG KONINKLIJKE PHILIPS NVR- NY 15.64 22.64B

About INGN

Company Profile

INGN logo image Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company is headquartered in Goleta, California and currently employs 766 full-time employees. The company went IPO on 2014-02-14. The company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. The company offers Simeox, which is an airway clearance device.

Company Info

INOGEN INC

859 Ward Drive

Goleta CALIFORNIA 93117 US

CEO: Nabil Shabshab

Employees: 766

INGN Company Website

INGN Investor Relations

Phone: 18055620500

INOGEN INC / INGN FAQ

What is the stock price of INOGEN INC today?

The current stock price of INGN is 7.07 USD. The price increased by 1.43% in the last trading session.


What is the ticker symbol for INOGEN INC stock?

The exchange symbol of INOGEN INC is INGN and it is listed on the Nasdaq exchange.


On which exchange is INGN stock listed?

INGN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for INOGEN INC stock?

9 analysts have analysed INGN and the average price target is 10.2 USD. This implies a price increase of 44.27% is expected in the next year compared to the current price of 7.07. Check the INOGEN INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is INOGEN INC worth?

INOGEN INC (INGN) has a market capitalization of 190.11M USD. This makes INGN a Micro Cap stock.


How many employees does INOGEN INC have?

INOGEN INC (INGN) currently has 766 employees.


What are the support and resistance levels for INOGEN INC (INGN) stock?

INOGEN INC (INGN) has a support level at 7.05 and a resistance level at 7.32. Check the full technical report for a detailed analysis of INGN support and resistance levels.


Is INOGEN INC (INGN) expected to grow?

The Revenue of INOGEN INC (INGN) is expected to grow by 7.03% in the next year. Check the estimates tab for more information on the INGN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy INOGEN INC (INGN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does INOGEN INC (INGN) stock pay dividends?

INGN does not pay a dividend.


When does INOGEN INC (INGN) report earnings?

INOGEN INC (INGN) will report earnings on 2025-05-07, after the market close.


What is the Price/Earnings (PE) ratio of INOGEN INC (INGN)?

INOGEN INC (INGN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.52).


What is the Short Interest ratio of INOGEN INC (INGN) stock?

The outstanding short interest for INOGEN INC (INGN) is 3.83% of its float. Check the ownership tab for more information on the INGN short interest.


INGN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

INGN Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to INGN. While INGN seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

INGN Financial Highlights

Over the last trailing twelve months INGN reported a non-GAAP Earnings per Share(EPS) of -1.52. The EPS increased by 49.16% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -12.12%
ROE -20.64%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%64.04%
Sales Q2Q%5.51%
EPS 1Y (TTM)49.16%
Revenue 1Y (TTM)6.34%

INGN Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 51% to INGN. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 7.06% and a revenue growth 7.03% for INGN


Ownership
Inst Owners89.01%
Ins Owners1.54%
Short Float %3.83%
Short Ratio2.56
Analysts
Analysts51.11
Price Target10.2 (44.27%)
EPS Next Y7.06%
Revenue Next Year7.03%